Abstracts – Mercury-All
July 04, 2017
Jin 2004-Thimerosal decreases TRPV1 activity by oxidation of extracellular sulfhydryl residues
July 04, 2017
Kaplin 1994 – Purified Reconstituted Inositol 1,4,5-Triphosphate Receptors
July 04, 2017
Karsen 2007 – Apparent vaccine-thimerosal induced hypersensitivity myelodysplastic syndrome and pancytopenia
July 04, 2017
Geier 2009 – A Prospective Study of Prenatal Mercury Exposure From Maternal Dental Amalgams and Autism Severity
July 04, 2017
Kempuraj 2010 – Mercury induces inflammatory mediator release from human mast cells
July 04, 2017
Kern 2010 – A biomarker of mercury body-burden correlated with diagnostic domain specific clinical symptoms of autism spectrum disorder
July 04, 2017
Geier 2009 – A Prospective Blinded Evaluation or Urinary Porphyrins Verses the Clinical Severity of Autism Spectrum Disorders
July 04, 2017
Kern 2010 – Toxicity biomarkers in autism spectrum disorder: A blinded study of urinary porphyrins
July 04, 2017
Geier 2008 – Neurodevelopment Disorders, Maternal Rh-Negativity, and Rho(D) Immune Globulins: A Multi-Center Assessment
July 04, 2017
Kern 2016 – The relationship between mercury and autism: A comprehensive review and discussion
July 04, 2017
Khan 2012 – Sex-dependent Changes in Cerebellar Thyroid Hormone-dependent Gene Expression Following Perinatal Exposure to Thimerosal in Rats
July 04, 2017
Kim 2002 – Thimerosal stimulates focal adhesion kinase and cytoskeletal changes by redox modulation
July 04, 2017
Geier 2006 – An Assessment of Downward Trends in Neurodevelopment Disorders in the United States Folloing Removal of Thimerosal from Childhood Vaccines
July 04, 2017
Kramer 2004 – Mercury exposure in protein A immunoadsorption
July 04, 2017
Lawton 2007 -Reduced tubulin tyrosination as an early marker of mercury toxicity in differentiating N2a cells
July 04, 2017
Geier 2006 – A Prospective Study of Thimerosal-containing Rho(D)-immune globulin Administration as a Risk Factor for Autistic Disorders
July 04, 2017
Lee 2006 – Thimerosal induces oxidative stress in HeLa S epithelial cells
July 04, 2017
Leventhal 2012 – Hypersensitivity Reactions to Vaccine Constituents: A Case Series and Review of the Literature
July 04, 2017
Li 2000 – Mercury intoxication presenting with tics
July 04, 2017
Geier 2006 – A Prospective Assessment of Porphyrins in Autistic Disorders: A Potential Marker for Heavy Metal Exposure
July 04, 2017
Li 2012 – Thimerosal-Induced Apoptosis in Mouse C2C12 Myoblast Cells Occurs through Suppression of the P13K/Akt/ Surviving Pathway
July 04, 2017
Madi 2004 – Being on the Track of Thimerosal
July 04, 2017
Geier 2005 – The Potential importance of Steroids in the Treatment of Autistic Spectrum Disorders and Other Disorders Involving Mercury Toxicity
July 04, 2017
Magos 2001 – Review on the Toxicity of Ethylmercury, Including its Presence as a Preservative in Biological and Pharmaceutical Products
July 04, 2017
Marques 2008 – Principal component analysis and discrimination of variables associated with pre- and post-natal exposure to mercury
July 04, 2017
Marques 2009 – Prenatal and Postnatal Mercury Exposure, Breastfeeding and Neurodevelopment During the First 5 Years
July 04, 2017
Marques 2010 – Thimerosal exposure (from tetanus-diphtheria) during pregnancy and neurodevelopment of breastfed infants at 6 months
July 04, 2017
Geier 2003 – Neurodevelopment Disorders after Thimerosal-containing Vaccines: A Brief Communication
July 04, 2017
Marques 2014 – Perinatal multiple exposure to neurotoxic (lead, methylmercury, ethylmercury, and aluminum) substances and neurodevelopment at six and 24 months of age
July 04, 2017
